
Biotin CAS: 58-85-5

Germany's seasonally adjusted chemical and pharmaceutical production declined 2.8% in the first quarter of 2026 and nearly 6% compared with the previous year. Procurement teams should assess how weaker European output may influence sourcing strategies, inventories and regional supply.

Japan's chemical industry enters H2 2026 after overcoming its most severe naphtha supply disruption in decades. The country's rapid diversification of feedstock sourcing may prove to be the most important long-term outcome of the Hormuz crisis, reshaping procurement strategies well beyond the recovery period.

Oman's proposal for maritime-services charges introduces a very different scenario from a geopolitical transit toll. Chemical buyers and logistics teams should understand how each approach could affect freight costs, compliance obligations and long-term sourcing decisions.

Sodium citrate supply is stabilizing as global logistics recover and freight costs begin easing. Hospital procurement teams should use the next 6–8 weeks to rebuild safety stock levels after months of inventory drawdown during the 2026 supply disruption.

Northeast Asia’s benzene market is showing early signs of recovery as cracker operations improve and Gulf supply routes reopen. This analysis explains how gradual supply restoration may affect downstream chemical buyers in Q3 2026.

India’s recent duty waiver for pharmaceutical intermediates has been a boon for global manufacturers, but the looming end of this policy raises concerns about rising import costs. This article examines the potential impact on API production, supply chains, and pricing strategies for stakeholders in the chemical industry.
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.